UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 179 filers reported holding UNIQURE NV in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,476 | -42.3% | 52,828 | -1.4% | 0.00% | -33.3% |
| Q2 2023 | $614,015 | -52.8% | 53,579 | -17.1% | 0.00% | -57.1% |
| Q1 2023 | $1,301,950 | -20.1% | 64,645 | -10.1% | 0.01% | -56.2% |
| Q4 2022 | $1,629,860 | -3.6% | 71,895 | -20.2% | 0.02% | -20.0% |
| Q3 2022 | $1,691,000 | -3.5% | 90,134 | -4.2% | 0.02% | +5.3% |
| Q2 2022 | $1,753,000 | +66.8% | 94,065 | +61.8% | 0.02% | +111.1% |
| Q1 2022 | $1,051,000 | -15.2% | 58,136 | -2.7% | 0.01% | -10.0% |
| Q4 2021 | $1,239,000 | +80.9% | 59,734 | +179.0% | 0.01% | +66.7% |
| Q3 2021 | $685,000 | +5.9% | 21,411 | +2.0% | 0.01% | 0.0% |
| Q2 2021 | $647,000 | – | 21,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |